HONG KONG, Apr 28, 2026 - (ACN Newswire via SeaPRwire.com) - The Census and Statistics Department today released the latest external merchandise trade statistics. In March 2026, the total value of Hong Kong’s merchandise exports recorded a year-on-year increase of 35.8% to HK$618.4 billion. For the first quarter of 2026, the total value of exports of goods amounted to HK$1,546.2 billion, representing a robust growth of 32.0% compared with the same period last year.Commenting on the outlook, Bruce Pang, Director of Research at the Hong Kong Trade Development Council, said Hong Kong’s exports are expected to remain steady at least in the near term, despite elevated energy prices arising from ongoing tensions in the Middle East. He noted Hong Kong’s external trade has continued to exhibit clear growth momentum, underpinned primarily by sustained global demand for electronic items and other intermediate goods that are integral to regional and global supply chains.In particular, resilient input demand from the Chinese Mainland and other ASEAN production sites, together with stable demand from major overseas markets, has provided a solid buffer against external headwinds. While geopolitical uncertainties persist and energy prices are likely to remain relatively high, continued industrial activity in major markets, as well as ongoing supply-chain realignments, are expected to lend ongoing support to Hong Kong’s trade flows.“Overall, we maintain a cautiously optimistic outlook for Hong Kong’s trade performance, while remaining mindful of potential volatility arising from geopolitical developments and cost pressures,” Pang added.HKTDC Media Room: https://mediaroom.hktdc.com/enMedia enquiriesPlease contact the HKTDC’s Communications & Public Affairs Department:Jane CheungTel: (852) 2584 4137Email: jane.mh.cheung@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
HONG KONG, Apr 28, 2026 - (ACN Newswire via SeaPRwire.com) - CanSino Biologics Inc. (688185.SH/06185.HK) released its first-quarter 2026 results, reflecting a positive operational momentum. Revenue for the quarter totaled RMB 190 million, representing a 38.73% year-over-year increase.The performance highlights the company’s strong operational resilience, driven by accelerating sales of core products and ongoing cost-efficiency measures. Despite short-term pressure on profitability, steady revenue expansion sets a solid foundation for a full-year earnings recovery.Menhycia(R), the first MCV4 vaccine product in China, maintained robust sales during the period. The successful launch of iPneucia(R) (13-valent pneumococcal polysaccharide conjugate vaccine) also contributed considerable revenue to the Group. Meanwhile, international technology transfer and intermediate products sales have gradually emerged as new revenue growth drivers.CanSinoBIO has developed a differentiated portfolio of bacterial vaccines, covering meningococcal, pneumococcal and DTcP vaccines. The company leverages five core technology platforms, including viral vector vaccines, synthetic vaccines, protein structure design and Virus-Like Particle (VLP) assembly, mRNA technologies, and formulation and delivery systems. This diversified pipeline helps mitigate the “single-product dependency” that has historically challenged traditional vaccine manufacturers.Among its key products, Menhycia(R), China’s first domestically developed quadrivalent meningococcal conjugate vaccine, has continued to gain market traction following approval for expanded use in children up to six years old, driving steady gains in market penetration. Meanwhile, iPneucia(R), China’s first 13-valent pneumococcal conjugate vaccine using a dual-carrier system (CRM197 and tetanus toxoid), has ramped up since launch and emerged as a key growth driver.In April, the company also received approval for Tripecia(R), an adsorbed acellular pertussis (three-component) combination vaccine (DTcP) for infants. Leveraging next-generation technology, the product fills a gap in the domestic market and further strengthens CanSinoBIO’s presence in the pediatric segment.Beyond the infant market, CanSinoBIO is advancing a “life-course immunization (from infancy through old age)” strategy, expanding into adolescent and adult vaccines. Pipeline candidates, including adolescent and adult component Tdap vaccines (Tdcp) and a 24-valent pneumococcal conjugate vaccine, are progressing through development and clinical trials, aimed at broadening the company’s addressable market.On the international front, the company continues to pursue a dual-engine strategy of innovation and global expansion, transitioning from product exports to a more integrated global model. Menhycia(R) has been launched and supplied in Indonesia, while manufacturing facilities for both Menhycia(R) and iPneucia(R) have obtained PIC/S GMP certification from Malaysia. This integrated approach, spanning product registration, localized manufacturing and technology transfer, is expected to unlock significant opportunities in overseas markets.Looking ahead, with the continued ramp-up of core products and the gradual commercialization of its life-course vaccine pipeline, CanSinoBIO’s long-term value proposition may be poised for a re-rating, supported by both earnings’ growth and an expanding global footprint. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
First phase drilling program underway at the 100% owned Condobolin epithermal gold, silver-base metals project located in the Cobar BasinCapital efficient sole funded drilling program of up to eight diamond core holes First systematic drilling in over a decade at the historic Condobolin Mineral Field Testing down dip, on strike, new adjacent coincident geochemical and geophysical targets at the high-grade Meritilga discovery Fully funded follow-up drilling proposed at Meritilga, with additional targets including other open prior discoveries and larger causative porphyry centers also under considerationRecent corporate activity highlights the value on high-grade projects in the Cobar BasinDrilling is ongoing in partnership with AngloGold Ashanti at the highly prospective Nevertire South porphyry project in the Macquarie ArcVancouver, British Columbia--(ACN Newswire via SeaPRwire.com - April 28, 2026) - Gold-copper explorer and hybrid project generator Kincora Copper Limited (ASX: KCC) (TSXV: KCC) (Kincora or the Company) is pleased to announce drilling has commenced at the Condobolin project, located in the southern end of the Cobar Basin in Central West NSW.John Holliday, Technical Committee chair, and Peter Leaman, VP of Exploration, commented,"We are very excited to be drilling at two highly prospective projects, including the first systematic drilling program in over a decade at our wholly owned Condobolin project. Our recent efforts have included consolidating the historic Condobolin mining field, an extensive airborne geophysical survey, a regional assessment of shallow historical workings, open prior explorer discoveries and potential causative porphyry targets.While water and the weathering profile previously impeded mining and exploration efforts those historic obstacles now support a compelling opportunity. The last phase of drilling delivered proof-of-concept with strong results and straightforward exploration upside at multiple historical mines and new discoveries, including a blind high-grade gold discovery at Meritilga. Cobar style deposits are often vertically extensive with repeating mineral systems. Our commenced program will, for the first time, properly test that potential at Mertiliga and advance our geological concept of a deeper intrusion(s) driving zoned hydrothermal systems across multiple historical mines and targets - offering both attractive grade and scale opportunity.Recent M&A in the Cobar district highlights the strategic value of high-grade precious and critical mineral deposits, particularly where synergies can be unlocked from existing processing capacity. The Condobolin project is an asset where a junior explorer like Kincora can add significant value." Figure 1: Kincora is currently sole-funding drilling at the Condobolin Mining Field while AngloGold Ashanti funds drilling (with Kincora receiving a management fee) at the Nevertire South license which is part of two earn-ins within the Northern Junee-Narromine Belt projectThe southern Cobar Basin remains relatively under-explored, with several recent discoveries in historic mining districtsTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/2305/294502_kincora_0427.jpgDistrict, regional and adjacent property information disclosed is provided for general awareness and educational purposes and is not necessarily indicative of any other project of the Company it is being compared to.ABOUT THE COBAR DISTRICTThe Cobar Basin has a 150-year history of high-grade, long-life mining and is an important supplier of critical and precious metals. The region benefits from established infrastructure and favourable ESG considerations with significant scope for processing and mining efficiencies, supporting further potential regional consolidation.The district has recently seen several significant new discoveries utilising modern exploration techniques in lesser explored regions (eg Federation, Achilles, Mallee Bull, Southern Nights and Wagga Tank) and emerging corporate activity (eg Harmony's A$1.6 billion takeover for MAC Copper (MAC.ASX), Aeris Resources A$214m acquisition of Peel Mining and Kingston Resources (KSN.ASX) recently receiving A$50 million cash for the first tranche of its divestment of its PNG Misima project).ABOUT THE CONDOBOLIN PROJECTThe Condobolin project was historically the focus of up to 25 informal open pit operations (peak late 1800's-early 1900's), with mining impacted by the water table and exploration by the weathering profile. The mineral field has not been effectively explored below the weathered zone (~30m).Very limited modern exploration has taken with initial activities by Clancy Exploration (Clancy, now RareX Limited) yielding encouraging results at all five prospects drilled (2011-13), including a virgin high-grade gold discovery at the Meritilga Prospect.More recently within the immediate district, Kingston Resources has significantly expanded the resources and restarted hard rock mining at the Mineral Hill mine, Talisman Mining has had success at its Rip N Tear and Durnings targets (to both the immediate north and south of Mineral Hill), while Australian Gold and Copper has excited the market with its new district scale discovery at its Achilles target located within the south western extension of the Cobar Basin.The Condobolin project is located approximately 40km south from the mill at Mineral Hill and north of the Condobolin town (which is the primary source of employees to Mineral Hill operation who drive through the Condobolin project to work) - see Figure 1.Kincora has consolidated a 100% project ownership and continued to expand our foothold across the near surface potential of the historical Condobolin Mineral Field. Approximately 20% of the wider project is out-sub cropping with the average depth of cover in non-outcropping areas less than 5 metres supporting very easy exploration with surface geology and sampling being an effective, quick and cheap methods.In 4Q'2025, the Company completed a ~150km2 airborne electro-magnetic (AEM) geophysical survey and the first systematic drilling program in over a decade commenced at the Meritilga target.Meritilga was a new blind shallow discovery made by Clancy in 2012 following up a coincident 2km x 2km arsenic-lead-zinc (+gold) geochemical anomaly and K-channel radiometric anomaly over ridges east of the historic mines at Mascotte and west of Potters. The anomalies coincided with key NE-striking structures identified in detailed 3D induced polarization (IP) surveys 1.The gold, silver and base metals system is situated within a lode with high grade lens (ore grade, eg 4m @ 20g/t gold, 30.2 g/t silver from 75m, including 1m @ 62g/t gold, 60g/t silver in hole CORC029) and a lower grade halo. The lode is a consistent body, open up and down dip 1, 2.Land access agreements are in place and the permitting process commenced for an up to 15 diamond drill hole program for 4100 metres testing down dip (up to 350m depth) and strike extensions and the potential for repeat high grade lens and/or a stacked series of lenses. Permits and land access are in place for a first phase program of up to eight holes.This setting is supported by the last phase of Reverse Circulation (RC) drilling by Clancy, the one diamond hole drilled by Kincora in 2023, coupled with a favourable structural setting where the main Meritilga Fault has been cross-cut by N-S trending faults 3.The program will also test new adjacent coincident geochemical and geophysical targets.The current working geological model, underpinned by pathfinder zonation and coincident geophysical anomalies, supports the potential for a larger mineralised intrusive source at depth, which this drilling program seeks to also support.ABOUT KINCORAKincora Copper Limited (ASX: KCC) (TSXV: KCC) is an emerging Australia-focused gold-copper explorer with a hybrid project generator strategy.The Company is successfully proving up the prospectivity of its extensive project portfolio, which includes multiple district-scale landholdings and scalable drill ready targets. These assets are located in Australia's Lachlan Fold Belt and Mongolia's Southern Gobi, two of the globe's leading porphyry belts, and the historical Condobolin mining field within the Cobar basin in NSW.The Company has already unlocked over $100 million of potential partner funding for multiple earlier stage and/or non-core porphyry projects. These initial deals have supported over 18,000 metres of drilling and over A$9m of partner funded exploration since late 2024, with management fees and exploration ramping up.Partner discussions are ongoing for its remaining 100% owned flagship projects that are all situated within existing porphyry camps containing over 20-million-ounce gold equivalent resource inventory.By having a significant portfolio of partner funded large porphyry projects, and a very focused capital efficient programs at the Condobolin and other sole funded projects, the Company is seeking to position Kincora as a leading institutional grade explorer in the public Australian and Canadian markets, and the leading project generator on the ASX.The Company's website is: www.kincoracopper.comThis announcement has been authorised for release by the Board of Kincora Copper Limited (ARBN 645 457 763)For further information please contact:Sam Spring, President and Chief Executive OfficerLaurie Thomas, Strategic Advisorsam.spring@kincoracopper.com or +61431 329 345laurie.thomas@kincoracopper.com or +1306 341 3826 Media contactJulia Maguire, Managing Director, The Capital Networkjulia@thecapitalnetwork.com.au or +61 2 7257 7338Executive office Subsidiary office Australia400 - 837 West Hastings StreetC/- JM Corporate ServicesVancouver, BC V6C 3N6, CanadaLevel 6, 350 Collins StreetTel: 1.604.283.1722Melbourne, VIC, Australia 3000 References:1 ASX release of Clancy Exploration Limited (now RareX Limited), titled "New Gold-Silver-Copper Discovery at Meritilga Prospect - Condobolin Project" dated March 20th, 2012, which can be obtained via the ASX website (www.asx.com.au). The Clancy results were reported in accordance with the version of the JORC Code existing prior to JORC 2012. Mining Associates has completed a review of sampling techniques and procedures dated January 31st, 2021, as outlined in the Independent Technical Report included in the ASX listing prospectus, which is available at: https://www.kincoracopper.com/investors/asx-prospectus. While the Company has no reason to believe the assay results are not reliable, the Company has not independently verified these results. The Company intends to conduct its own exploration programme as described in this release.2 ASX release of Clancy Exploration Limited (now RareX Limited), titled "Condobolin Project Yields Visible Gold and Potential Alluvial Gold" dated January 20th, 2012, which can be obtained via the ASX website (www.asx.com.au). The Clancy results were reported in accordance with the version of the JORC Code existing prior to JORC 2012. Mining Associates has completed a review of sampling techniques and procedures dated January 31st, 2021, as outlined in the Independent Technical Report included in the ASX listing prospectus, which is available at: https://www.kincoracopper.com/investors/asx-prospectus. While the Company has no reason to believe the assay results are not reliable, the Company has not independently verified these results. The Company intends to conduct its own exploration programme as described in this release.3 ASX release of Clancy Exploration Limited (now RareX Limited), titled "Gold and Silver Hits Extend Meritilga Lode" dated Jube 17th, 2013, which can be obtained via the ASX website (www.asx.com.au). The Clancy results were reported in accordance with the version of the JORC Code existing prior to JORC 2012. Mining Associates has completed a review of sampling techniques and procedures dated January 31st, 2021, as outlined in the Independent Technical Report included in the ASX listing prospectus, which is available at: https://www.kincoracopper.com/investors/asx-prospectus. While the Company has no reason to believe the assay results are not reliable, the Company has not independently verified these results. The Company intends to conduct its own exploration programme as described in this release.Forward-Looking StatementsCertain information regarding Kincora contained herein may constitute forward-looking statements within the meaning of applicable securities laws. Such forward-looking statements or information include but are not limited to statements or information with respect to: the Condobolin project, the drilling program in the Condobolin project, future growth, results and targets of Company drilling and other exploration activities and programs, open prior discoveries and larger causative porphyry center targets. Forward-looking statements may include estimates, plans, expectations, opinions, forecasts, projections, guidance or other statements that are not statements of fact. Readers are cautioned not to place undue reliance on forward-looking information and statements.Forward-looking information involves numerous risks and uncertainties, and actual results might differ materially from results suggested in any forward-looking information. These risks and uncertainties include, among other items: market prices, exploitation and exploration results, continued availability of capital and financing and general economic, market, or business conditions. Although Kincora believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Kincora cautions that actual performance will be affected by a number of factors, most of which are beyond its control, and that future events and results may vary substantially from what Kincora currently foresees. Factors that could cause actual results to differ materially from those in forward-looking statements include: market prices; exploitation and exploration results; continued availability of capital and financing and general economic; market or business conditions; and, investor sentiment. Accordingly, readers should not place undue reliance on forward-looking information and statements. Readers are cautioned that reliance on such information and statements may not be appropriate for other purposes.The forward-looking statements are expressly qualified in their entirety by this cautionary statement. The information contained herein is stated as of the current date and is subject to change after that date. Kincora does not assume the obligation to revise or update these forward-looking statements, except as may be required under applicable securities laws.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) or the Australian Securities Exchange accepts responsibility for the adequacy or accuracy of this release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/294502 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
West Palm Beach, FL, Apr 28, 2026 - (ACN Newswire via SeaPRwire.com) - U.S. Polo Assn., the official sports brand of the United States Polo Association (USPA), capped the American polo season with a thrilling finale as the 2026 U.S. Open Polo Championship® Final took center stage on April 26 at the USPA National Polo Center in Palm Beach County, Florida. Played on the iconic U.S. Polo Assn. Stadium Field, the most prestigious tournament in American polo, delivered elite international competition, worldwide broadcast exposure on ESPN, and an exciting Championship Sunday experience that resonated both on and off the field before a record crowd.U.S. Open Polo Championship Trophy with Team Pilot (L to R; Patron Curtis Pilot, Mackenzie Weisz, Camilo ‘Jeta' Castagnola, Lorenzo Chavanne)Pilot's Camilo ‘Jeta' Castagnola Scoring the Final Goal of the U.S. Open Polo Championship Final, Securing Pilot's Victory with a Score of 15-10Bob Bryan (R), One of the Greatest Doubles Tennis Players of All Time, Alongside USPA National Polo Center Tennis Professional Scott Williams (L), Conducting the Ceremonial Pre-Game Coin Toss at the U.S. Open Polo Championship FinalNashville Country Artist Abbey Cone Singing the National Anthem to a Record-Breaking Crowd for the U.S. Open Polo Championship Final at the USPA National Polo CenterBTA Mounted and Ready to Compete Against Pilot in the Prestigious U.S. Open Polo Championship Final U.S. Polo Assn. Models at the USPA Shop at NPC for the U.S. Open Polo Championship FinalPhoto Credit: Agustina FondaThe third and final chapter of the three-tournament Gauntlet of Polo® series brought together 11 top teams and many of the sport's most accomplished players, including 10-goal standouts Adolfo and Poroto Cambiaso, Hilario Ulloa, Tomas Panelo, and Jeta and Barto Castagnola. Other standout talents include Jesse Bray (7-goal), Lorenzo Chavanne (7-goal), Mackenzie Weisz (6-goal), Rufino Merlos (6-goal), Nico Escobar (6-goal), and Timmy Dutta (4-goal), to name a few. Rising stars and seasoned competitors alike, along with their equine partners, contributed to a highly competitive season that culminated in a Final that showcased something for everyone.To amplify the global reach of the event, the U.S. Open Polo Championship Final will once again be featured across ESPN platforms, with legendary commentator Chris Fowler hosting for the second consecutive year, alongside Kenny Rice, Polo Hall-of-Famer Adam Snow, and Karl Ude-Martinez. The broadcast, also available via Global Polo's YouTube, brings the excitement of the U.S. Open Polo Championship to a worldwide audience. Check local listings for airtimes.U.S. Open Polo Championship® Final at a Glance:Final Matchup: Pilot (#1 Curtis Pilot - 0, #2 Mackenzie Weisz - 6, #3 Lorenzo Chavanne - 7, #4 Camilo ‘Jeta' Castagnola - 10) vs. BTA (#1 KC Krueger - 1, #2 Steve Krueger - 5, #3 Tomas Panelo - 10, #4 Ignacio ‘Nachi' Viana -7)Date: April 26, 2026Location: USPA National Polo Center, Wellington, Florida, on the U.S. Polo Assn. Stadium FieldFinal Score: 15 (Pilot) - 10 (BTA)MVP: Lorenzo Chavanne (Pilot)Best Playing Pony: Open Texas, ridden by Lorenzo ChavanneBest Playing Pony, Argentinian Bred: Open Silaba, ridden by Lorenzo ChavanneU.S. Polo Assn. Sportsmanship Award, Presented by YETI: Steve Krueger (BTA)Skeeter Johnston - Sponsor of the Year: KC Krueger (BTA)Charity Beneficiaries: Polo Training Foundation (Pilot) and Museum of Polo & Hall of Fame (BTA)Broadcast: ESPN Platforms (Hosted by Chris Fowler with Kenny Rice, Adam Snow, and Karl Ude-Martinez), and Global Polo YouTubeGame Highlights: Pilot controlled the pace from the opening chukker, maintaining a strong multi-goal advantage that stretched to five goals midway through the third chukker. Despite the deficit, BTA regrouped at halftime and mounted an impressive push, narrowing the gap to a one-goal game in the second half. Pilot, however, never relinquished control, responding with precision to halt the momentum and rebuild their lead. In the final chukker, Pilot added two more goals to secure a 15-10 victory and back-to-back tournament wins following the USPA Gold Cup®. Lorenzo Chavanne and Camilo ‘Jeta' Castagnola led all scorers, each tallying seven goals in a standout offensive performance for the U.S. Open Polo Championship® Final.On Sunday, the BTA Team made history with its first-ever appearance in the U.S. Open Polo Championship® Final, featuring a husband-and-wife duo competing side by side. The game also marked a significant moment for the sport, with the BTA's female player making her U.S. Open Polo Championship debut, the first woman to make it to the Finals since Gillian Johnston won the U.S. Open Polo Championship in 2002, reflecting the sport's unique format where men and women play together on the field. Team Pilot entered the Final with strong momentum, seeking back-to-back major titles following their 2026 USPA Gold Cup victory.As the Official Sports Brand of the USPA, U.S. Polo Assn.'s presence was felt throughout the prestigious tournament, from outfitting teams with the brand's iconic Double Horsemen logo along with all NPC staff to creating immersive fan touchpoints across the venue. The sports brand also reinforced its commitment to the sport of polo and its community by making charitable donations to multiple polo and equine-based charities selected by finalist teams at all tournaments throughout the season."From a record-breaking season at the USPA National Polo Center to one of the most anticipated championship finals in the sport of polo, the U.S. Open Polo Championship® continues to raise the bar for our sport in the United States and around the world," said J. Michael Prince, President and CEO of USPA Global, the company that manages the multi-billion-dollar U.S. Polo Assn. brand. "Through U.S. Polo Assn.'s ongoing support and platforms like ESPN, we are able to bring the energy and tradition of this championship final to audiences around the world while continuing to create new fans and grow our sport and brand for future generations."Beyond the competition, Championship Sunday of the U.S. Open Polo Championship offered a vibrant, entertainment-driven atmosphere that resonated with longtime fans and new audiences alike. Tennis legend Bob Bryan of the Bryan Brothers delivered the ceremonial coin toss, while Nashville rising artist Abbey Cone performed the National Anthem. Guests enjoyed live music from Cone throughout the day, from pre-match moments at the Asado area to upbeat sounds during the traditional halftime divot stomp.U.S. Polo Assn. further elevated the on-site experience through curated retail and lifestyle activations at the USPA Shop at NPC, including a stunning polo artwork gallery featuring globally acclaimed equine artist Eduardo Marquez, the return of the interactive and eye-catching Briny Brim Custom Hat Bar, and complimentary chilled Limited Edition U.S. Polo Assn. rose served on the shop's porch, just beside the brand's polo ball photo wall for the perfect game day memory. Fans also took part in the iconic divot stomp tradition, receiving commemorative red, white, and blue caps in honor of the United States' 250th Anniversary.Established in 1904, the U.S. Open Polo Championship remains the definite test of excellence in American polo and a cornerstone of the international polo calendar, drawing the sport's top talent and passionate fans to Wellington, the Winter Equestrian Capital of the World, each season.B-Roll: https://f.io/lT0GXdwCAbout U.S. Polo Assn. and USPA GlobalU.S. Polo Assn. is the official sports brand of the United States Polo Association (USPA), the largest association of polo clubs and polo players in the United States, founded in 1890. With a multi-billion-dollar global footprint and worldwide distribution through more than 1,200 U.S. Polo Assn. retail stores as well as thousands of additional points of distribution, U.S. Polo Assn. offers apparel, accessories, and footwear for men, women, and children in more than 190 countries worldwide. The brand sponsors major polo events around the world, including the U.S. Open Polo Championship®, held annually at NPC in The Palm Beaches, the premier polo tournament in the United States. Historic deals with ESPN in the United States, TNT and Eurosport in Europe, Star Sports in India, and BeIn Sports in the Middle East now broadcast several of the premier polo championships in the world, sponsored by U.S. Polo Assn., making the thrilling sport accessible to millions of sports fans globally for the very first time.U.S. Polo Assn. has consistently been named one of the top global sports licensors in the world alongside the NFL, PGA Tour, and Formula 1, according to License Global. In addition, the sport-inspired brand is being recognized internationally with awards for global growth and sport content. Due to its tremendous success as a global brand, U.S. Polo Assn. has been featured in Forbes, Fortune, Modern Retail, and GQ as well as on Yahoo Finance and Bloomberg, among many other noteworthy media sources around the world. For more information, visit uspoloassnglobal.com and follow @uspoloassn.USPA Global is a subsidiary of the United States Polo Association (USPA) and manages the multi-billion-dollar sports brand, U.S. Polo Assn. USPA Global also manages the subsidiary, Global Polo, which is the worldwide leader in polo sport content. To learn more, visit globalpolo.com or Global Polo on YouTube.For Additional Information, Contact:Stacey Kovalsky - VP, Global PR and CommunicationsPhone +001.561.790.8036 - E-mail: skovalsky@uspagl.comShannon Stilson - VP, Sports Marketing and MediaPhone +001.561.227.6994 - E-mail: sstilson@uspagl.comSOURCE: U.S. Polo Assn. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
佛罗里达州西棕榈滩, 2026年4月28日 - (亚太商讯 via SeaPRwire.com) - 作为美国马球协会（USPA）的官方运动品牌，U.S. Polo Assn. 以一场激动人心的决赛为美国马球赛季画上了圆满句号。4月26日，2026年美国公开马球锦标赛®决赛在佛罗里达州棕榈滩县的USPA国家马球中心隆重举行。这场在美国马球协会标志性的体育场内举行的赛事，作为美国马球界最负盛名的锦标赛，不仅呈现了国际顶尖水平的竞技对决，还通过ESPN实现了全球直播，更在创纪录的观众面前，打造了一场场内场外皆令人振奋的“冠军周日”盛宴。1. 美国公开马球锦标赛奖杯与Pilot队（从左至右：赞助人柯蒂斯·皮洛特、麦肯齐·韦兹、卡米洛·“杰塔”·卡斯塔尼奥拉、洛伦佐·查万）2. Pilot队的卡米洛·“杰塔”·卡斯塔尼奥拉在美国公开马球锦标赛决赛中打入制胜一球，最终Pilot队以15比10的比分锁定胜局3. 鲍勃·布莱恩（右），史上最伟大的双打网球选手之一，与美国马球协会国家马球中心网球职业选手斯科特·威廉姆斯（左）一同在美国公开赛马球锦标赛决赛中主持赛前仪式性的抛硬币环节4. 纳什维尔乡村歌手艾比·科恩在美国马球协会国家马球中心举行的美国公开马球锦标赛决赛上，为创纪录的观众群演唱了国歌5. BTA已整装待发，将在备受瞩目的美国公开马球锦标赛决赛中迎战Pilot队 6. 美国马球协会（U.S. Polo Assn.）的模特们现身NPC的USPA专卖店，为美国马球公开赛决赛助阵图片来源：Agustina Fonda“Gauntlet of Polo®”系列赛的第三站暨收官之战汇聚了11支顶尖球队以及众多该项运动中最杰出的球员，其中包括10分级别的明星球员阿道夫·坎比亚索、波罗托·坎比亚索、希拉里奥·乌洛亚、托马斯·帕内洛，以及杰塔·卡斯塔尼奥拉和巴托·卡斯塔尼奥拉。其他杰出选手还包括杰西·布雷（7分）、洛伦佐·查万（7分）、麦肯齐·韦兹（6分）、鲁菲诺·梅尔洛斯（6分）、尼科·埃斯科巴（6分）和蒂米·杜塔（4分）等。无论是新星还是老将，他们与自己的马匹搭档共同奉献了一个竞争激烈的赛季，最终在决赛中为观众呈现了一场精彩纷呈的盛宴。为扩大赛事的全球影响力，美国公开马球锦标赛决赛将再次登陆ESPN各平台。传奇解说员克里斯·福勒将连续第二年担任主持，与肯尼·赖斯、马球名人堂成员亚当·斯诺以及卡尔·乌德-马丁内斯共同解说。该转播也可通过Global Polo的YouTube频道观看，将美国公开马球锦标赛的激情带给全球观众。具体播出时间请查阅当地节目表。美国公开马球锦标赛®决赛一览：· 决赛对阵：Pilot队（1号库尔蒂斯·皮洛特 - 0，2号麦肯齐·韦兹 - 6， 3号洛伦佐·查万 - 7，4号卡米洛·“杰塔”·卡斯塔尼奥拉 - 10）对阵 BTA（1号KC·克鲁格 - 1，2号史蒂夫·克鲁格 - 5，3号托马斯·帕内洛 - 10，4号伊格纳西奥·“纳奇”·维亚纳 - 7）· 日期：2026年4月26日· 地点：佛罗里达州韦灵顿市美国马球协会国家马球中心，美国马球协会体育场· 最终比分：15（Pilot）- 10（BTA）· 最有价值球员：洛伦佐·查万（Pilot）· 最佳赛驹奖：《德克萨斯公开赛》，骑手：洛伦佐·夏万· 最佳表演马（阿根廷育种）：公开组“西拉巴”，骑手洛伦佐·查万· 由YETI呈献的美国马球协会体育精神奖：史蒂夫·克鲁格（BTA）· 斯基特·约翰斯顿——年度赞助商：KC·克鲁格（BTA）· 慈善受益方：马球培训基金会（Pilot）和马球博物馆及名人堂（BTA）· 直播平台：ESPN平台（由克里斯·福勒主持，肯尼·赖斯、亚当·斯诺和卡尔·乌德-马丁内斯参与解说），以及Global Polo YouTube频道· 比赛亮点：Pilot队从首节开始就掌控了比赛节奏，始终保持着多球领先优势，并在第三节中段将分差扩大至五球。尽管处于落后，BTA队在半场休息时重新整顿，并在下半场发起猛烈反扑，将分差缩小至仅一球。然而，Pilot队始终未曾松懈，凭借精准的应对遏制了对手的攻势，并重新确立了领先优势。在最后一节比赛中，Pilot队再入两球，最终以15-10获胜，继USPA金杯赛®之后，连续两届夺得锦标赛冠军。洛伦佐·查万（Lorenzo Chavanne）和卡米洛·“杰塔”·卡斯塔尼奥拉（Camilo ‘Jeta’ Castagnola）在美式马球公开赛®决赛中表现抢眼，各自攻入七球，成为全场得分王。周日，BTA队创造了历史，首次闯入美国公开马球锦标赛®决赛，比赛中一对夫妻搭档并肩作战。本场比赛对这项运动而言也具有重要意义：BTA队的女选手首次亮相美国公开马球锦标赛，成为自2002年吉莉安·约翰斯顿夺冠以来首位跻身决赛的女性选手，这充分体现了该运动独特的赛制——男女选手同场竞技。Pilot队以强劲势头挺进决赛，力求继2026年USPA金杯赛夺冠后实现重大赛事两连冠。作为美国马球协会（USPA）的官方运动品牌，U.S. Polo Assn.在整个这项声望卓著的赛事中无处不在：从为参赛队伍及国家马球中心（NPC）全体工作人员配备印有品牌标志性双骑士标识的装备，到在赛场各处打造沉浸式的球迷互动体验。该运动品牌还通过向决赛队伍在整个赛季所有赛事中选定的多家马球及马术慈善机构进行捐赠，进一步彰显了其对马球运动及其社区的承诺。“从美国马球协会国家马球中心创纪录的赛季，到马球运动中最受瞩目的冠军决赛之一，美国公开马球锦标赛®持续为美国乃至全球的马球运动树立新标杆，”管理着价值数十亿美元的U.S. Polo Assn.品牌的USPA Global公司总裁兼首席执行官J. Michael Prince表示。“借助美国马球协会的持续支持以及ESPN等平台，我们不仅能将这场冠军决赛的激情与传统传递给全球观众，还能持续吸引新粉丝，为子孙后代发展这项运动和品牌。”除了比赛本身，美国马球公开赛的“冠军周日”还营造出一种充满活力、以娱乐为主导的氛围，深受老粉丝和新观众的喜爱。网球传奇人物、布莱恩兄弟组合的鲍勃·布莱恩主持了开赛硬币掷选仪式，而纳什维尔新锐歌手艾比·科恩则献唱了国歌。从赛前阿萨多（Asado）区域的暖场时刻，到传统中场草皮踩踏环节的欢快旋律，宾客们全天沉浸在科恩带来的现场音乐中。U.S. Polo Assn. 通过在NPC的USPA商店内精心策划的零售及生活方式体验活动，进一步提升了现场体验。其中包括展示全球知名马术艺术家爱德华多·马奎兹（Eduardo Marquez）作品的惊艳马球艺术画廊、备受瞩目的互动式Briny Brim定制帽吧的回归，以及在商店门廊旁——紧邻品牌马球照片墙处——免费供应的冰镇限量版U.S. Polo Assn.玫瑰酒，为观众留下了完美的比赛日回忆。球迷们还参与了标志性的“踩草皮”传统活动，并获赠了红、白、蓝三色纪念帽，以庆祝美国建国250周年。创立于1904年的美国公开马球锦标赛，至今仍是检验美国马球卓越水平的终极试金石，也是国际马球赛事日历上的基石。每赛季，这项赛事都会将该运动的顶尖人才和热情的球迷吸引到“世界冬季马术之都”惠灵顿。B-Roll: https://f.io/lT0GXdwC关于 U.S. Polo Assn. 和 USPA GlobalU.S. Polo Assn. 是美国马球协会（USPA）的官方运动品牌，该协会成立于1890年，是美国规模最大的马球俱乐部和马球运动员组织。U.S. Polo Assn. 业务规模达数十亿美元，通过全球1,200多家直营门店及数千个其他销售网点，向全球190多个国家的消费者提供男女及儿童服饰、配饰和鞋履。该品牌赞助了全球各大马球赛事，包括每年在棕榈滩的NPC举行的美国公开马球锦标赛®——这是美国最顶级的马球赛事。通过与美国ESPN、欧洲TNT和Eurosport、印度Star Sports以及中东BeIn Sports达成的历史性合作，由U.S. Polo Assn.赞助的数项世界顶级马球锦标赛现已实现转播，使这项激动人心的运动首次触达全球数百万体育迷。据《License Global》报道，U.S. Polo Assn. 一直与NFL、PGA巡回赛和一级方程式（F1）并列，被评为全球顶尖体育授权商之一。此外，这一受运动启发的品牌因在全球市场拓展及体育内容方面的卓越表现，屡获国际奖项认可。凭借其作为全球品牌的巨大成功，U.S. Polo Assn. 不仅登上了《福布斯》、《财富》、《现代零售》和《GQ》等杂志，还出现在雅虎财经和彭博社等全球众多知名媒体上。如需了解更多信息，请访问 uspoloassnglobal.com 并关注 @uspoloassn。USPA Global 是美国马球协会（USPA）的子公司，负责运营价值数十亿美元的体育品牌 U.S. Polo Assn.。USPA Global 还管理其子公司 Global Polo，后者是全球马球运动内容的领导者。如需了解更多信息，请访问 globalpolo.com 或在 YouTube 上关注 Global Polo。如需更多信息，请联系：Stacey Kovalsky - VP, Global PR and CommunicationsPhone +001.561.790.8036 - E-mail: skovalsky@uspagl.comShannon Stilson - VP, Sports Marketing and MediaPhone +001.561.227.6994 - E-mail: sstilson@uspagl.com来源：U.S. Polo Assn. Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
香港, 2026年4月28日 - (亚太商讯 via SeaPRwire.com) - 康希诺生物（688185.SH/06185.HK）4月28日发布2026年第一季度财报。报告显示，公司一季度实现营业收入1.90亿元，同比增长38.73%，彰显了公司在核心产品放量与降本增效策略下的强劲经营韧性。尽管短期利润承压，但营业收入的稳健增长仍为全年业绩修复奠定了坚实基础。具体来看，曼海欣®作为中国首款四价流脑结合疫苗，销售收入保持同期较高水平；13价肺炎球菌多糖结合疫苗优佩欣®的成功上市亦为本集团贡献了可观收入；同时， 国际技术转移及中间品销售业务正逐步成为本集团新的收入增长点。作为国内领先的创新细菌性疫苗企业，康希诺生物依托病毒载体疫苗、合成疫苗、蛋白结构设计与VLP组装、mRNA疫苗以及制剂与给药技术五大核心技术平台，已构建起覆盖脑膜炎、肺炎、百白破等多领域的差异化产品矩阵，有效破解了传统疫苗企业面临的"单品依赖"难题。整体而言，中国首款四价流脑结合疫苗曼海欣®（MCV4）在获批扩龄至6周岁后，市场渗透率持续提升，继续保持稳健增长；国内首款采用CRM197+TT双载体蛋白技术的13价肺炎结合疫苗优佩欣®（PCV13i）上市后快速放量，已成为业绩增长的新引擎。此外，公司于2026年4月刚刚获批的婴幼儿用吸附无细胞百（三组分）白破联合疫苗盼康欣®，凭借技术代际优势填补了国内市场空白，进一步完善了公司在婴幼儿疫苗领域的布局。值得一提的是，公司正积极践行"全生命周期免疫"理念，加速推进青少年及成人用组分百白破疫苗Tdcp、24价肺炎球菌多糖结合疫苗等管线的研发与临床进程，旨在将产品线延伸至成人市场，从而打破单一细分市场的天花板限制。在国际化战略上，公司坚持"创新+全球市场"双轮驱动，加速从"产品出海"向"体系出海"升级。目前，曼海欣®已在印尼实现首发上市并启动供应，曼海欣®和优佩欣®生产基地也获得马来西亚PIC/S GMP认证。这种涵盖产品注册、本地化生产到技术转移的全方位出海模式，将为公司打开广阔的海外市场空间。展望未来，随着核心产品的持续放量以及全生命周期产品管线的逐步兑现，康希诺生物的长期价值有望在业绩增长与全球化布局的双重驱动下迎来重估。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
(AsiaGameHub) - A study conducted by the University of Cambridge has intensified the discussion surrounding gambling advertisements in Ireland, coinciding with broader concerns about the gambling industry's societal effects within the nation.
Ireland is currently undergoing a period of regulatory reform, with the Gambling Regulatory Authority of Ireland (GRAI) now overseeing the country’s betting market as mandated by the 2024 Gambling Regulation Act.
Similar to the review of the Gambling Act in the United Kingdom, the re-regulation of Ireland's betting market has left proponents of gambling reform, such as the Labour Party, advocating for more substantial changes to advertising regulations.
According to research jointly undertaken by the University of Cambridge and Munster Technological University (MTU) in Cork, gambling advertisements in Ireland disproportionately affect young men.
The university's study examined social media advertising through the Meta Ad library, analyzing published advertisements and demographic data across platforms like Facebook and Instagram.
Dr Elena Petrovskaya, the lead author of the report from the university’s Department of Computer Science and Technology, noted that "not that many adverts directly targeted men to begin with."
However, she elaborated: "But even when adverts were set to reach all genders, they still reached that very vulnerable group of young men.
“It shows that if companies just put ads on social media, they are still reaching young men – the group we know from other research is most at risk of gambling harms.”
Cambridge researchers analyzed 411 advertisements from 88 licensed Irish operators, concluding that young men were 2.3 times more likely to be exposed to social media advertisements than women, despite the ads not being specifically targeted at men.
Individuals in the 25-34 age group constituted one-third of all unique accounts reached, accumulating 6.2 million impressions. The researchers highlighted one particular advertisement that reached 1.32 million unique accounts.
Irish advertising debate continues unabated
The discourse concerning gambling in Ireland, much like in other significant European gambling markets such as the UK, Netherlands, and Italy, has largely centered on sponsorship arrangements.
The presence of bookmaker branding in prominent Irish sports competitions, including the Gaelic football and hurling leagues of the Gaelic Athletic Association (GAA) and the League of Ireland (LOI), has been a contentious issue for many years.
The GAA ultimately decided to cease partnerships with gambling sponsors, citing concerns regarding customer protection and societal impact. The LOI, in contrast to its English counterparts in the EFL and the governing bodies of the Premier League, has been more reluctant to sever commercial ties with the sport due to the revenue generated.
The Gambling Regulation Act and the GRAI's mandate are now established, with the latter assuming licensing responsibilities this year. Nevertheless, certain political figures, such as Labour Party leader Ivana Bacik, remain firm in their conviction that a comprehensive ban on gambling advertising in Ireland is essential.
Research from institutions like Cambridge and MTU is expected to play a significant role in this debate, particularly given its focus on the impact of social media advertising, adding another dimension to a discussion that has predominantly revolved around sports sponsorships and television commercials.
The findings from the researchers regarding the impact of advertising on young men, who according to Irish government statistics are among those most susceptible to gambling-related harm, will be particularly important for advocates of gambling reform.
“This research provides valuable insights that establish a baseline for the reach of gambling advertising on social media in Ireland before the introduction of a regulatory framework,” stated Dr Deirdre Leahy from MTU, a co-author of the research.
“This baseline will be essential for assessing the impact of reforms under the Gambling Regulation Act.”
This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content.
AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
- In collaboration with the Shell Foundation and Double Feather Partners, NEC is promoting startups and solutions to social issues -TOKYO, Apr 28, 2026 - (JCN Newswire via SeaPRwire.com) - NEC Corporation (TSE: 6701) has launched an initiative to strengthen collaboration with African startups and address social challenges such as agriculture and food security. The newly established "Africa Corporate Innovation Program" is in addition to NEC’s existing global startup accelerator, the "NEC Innovation Challenge", and is designed to further strengthen partnerships with startups. The program will be jointly designed and implemented by the UK-based Shell Foundation charity (Note 1) and the Double Feather Partners (Note 2, hereafter DFP) venture capital firm.NEC has been working to achieve sustainable agriculture and stronger food security in Africa by combining its advanced technological capabilities with practical insights gained from global business operations, including the provision of data-driven farming solutions.NEC has hosted the NEC Innovation Challenge since 2022 to promote co-creation with global startups. In 2024 and 2025, NEC also participated in Project NINJA (Note 3) for building startup ecosystems for innovation creation in developing countries, led by the Japan International Cooperation Agency (JICA) (Note 4), further advancing open innovation globally.Building on these initiatives, NEC began implementing the Africa Corporate Innovation Program this April in collaboration with Shell Foundation, the UK registered charity empowering underserved customers to raise their incomes while lowering emissions with funding by the UK Government via the Research on Infrastructure in Developing Economies (RIDE) program and DFP, which has strong capabilities in local co-creation design and business scaling support in Africa.Through this program, startups capable of addressing key challenges in Africa will be selected and will collaborate with NEC and partners to conduct proof-of-concept (PoC) demonstration projects that leverage the strengths of each party. Based on the outcomes of these projects, the initiative will also explore mid- to long-term business development and strategic partnerships, aiming to establish sustainable co-creation models.Program OverviewThe program leverages NEC’s ICT platform "CropScope" to build agricultural technologies, including farm to market logistics solutions, while conducting proof-of-concept (PoC) trials with African startups to establish evidence for longer-term commercial partnerships and expansion across African markets.ScheduleApril 2026:Launch of the Africa Corporate Innovation ProgramInitiate collaboration with African startupsThrough December 2026:PoC projects utilizing agricultural fields in AfricaMarch 2027:Evaluation of PoC outcomes and impact measurement, followed by a final reporting sessionMasayuki FurukawaDirector, Private Sector Development GroupJapan International Cooperation Agency (JICA)"JICA has been continuously conducting cooperation in collaboration with private-sector partners with the aim of strengthening startup ecosystems in Africa and enhancing collaboration between African and Japanese companies."This initiative holds significant value where it leverages the experience and knowledge accumulated through the Next Innovation with Japan (NINJA) project promoted by JICA, with the expectation of contributing further to Africa’s economic development. JICA supports the idea that private companies take the lead in addressing social challenges in Africa and building mutually beneficial relationships."Furthermore, JICA hopes that this initiative will encourage more Japanese companies to participate in similar efforts, thereby further expanding collaboration between startups in Japan and Africa. JICA will continue its cooperation through Project NINJA and will support promoting initiatives of this kind going forward."Jonathan BermanCEOShell Foundation"Raising incomes for people on low incomes while supporting a low carbon pathway requires more than good ideas – it requires partnerships that bring together capital, technology and local entrepreneurial expertise. Through the Africa Corporate Innovation Program, Shell Foundation is using catalytic funding to reduce the risk of collaboration and, together with our partner Double Feather Partners, help global corporates like NEC work alongside African startups to test, learn and build solutions that can scale and evolve into sustainable business partnerships. Our role is to make these partnerships possible, prove what works in practice and help unlock much larger flows of capital into inclusive, climate-smart markets."Kohei MutoRepresentative Director & CEODouble Feather Partners"Social challenges in Africa should no longer be viewed merely as development issues; they represent the frontier of one of the world’s fastest-evolving innovation markets. This program serves as an implementation platform that connects the technological strengths of Japanese companies with the field-driven innovation capabilities of African startups."DFP will design and support mechanisms that connect PoC initiatives to investment opportunities and business scale-up, maximizing NEC’s business expansion and social impact creation in Africa. In collaboration with the Shell Foundation, DFP will also support the development of sustainable business models from the perspectives of impact investment and blended finance."Through this initiative, we aim to build a new co-creation model between Japan and Africa, enabling a seamless pathway from demonstration projects to capital linkage and ultimately to business value creation."NEC is scheduled to present background on this project at the "SusHi Tech Tokyo 2026" innovation conference, held from April 27th (Monday) to 29th (Wednesday), 2026. Please see below for details.Title: Beyond Capital: Building Japan–Africa Innovation Through Co-Creation and InvestmentDate and Time: April 27th (Monday), 5:05PM-5:50PMLocation: Investor’s Stage, West 3-4 Hall 4F (Upper Floor), Tokyo Big SightParticipating Companies:Double Feather Partners, Japan International Cooperation Agency (JICA), Shell Foundation, NEC, Industrial Development Corporation of South Africa (IDC), and Absa BankFor details and registration information for SusHi Tech Tokyo 2026, please visit the official website. https://sushitech-startup.metro.tokyo.lg.jp/en/Under the key message "The future is ours to shape," NEC drives "NEC Open Innovation" (Note 5) in new business development through diverse co-creation with startups and partner companies. The Africa Corporate Innovation Program is part of that effort, and by combining cutting-edge technologies with cross-sector collaboration, NEC continues to generate new social value and shape the future.1. Shell Foundation: https://shellfoundation.org/ 2. Double Feather Partners: https://doublefeather.com/ 3. Project NINJA4. Japan International Cooperation Agency (JICA)https://www.jica.go.jp/english/index.html5. NEC Open Innovationhttps://www.nec.com/en/global/innovation/index.htmlAbout NECThe NEC Group leverages technology to create social value and promote a more sustainable world where everyone has the chance to reach their full potential. NEC Corporation was established in 1899. Today, the NEC Group’s approximately 110,000 employees utilize world-leading AI, security, and communications technologies to solve the most pressing needs of customers and society.For more information, please visit https://www.nec.com. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
(AsiaGameHub) - Australia’s leading casino brand The Star Entertainment Group has recorded a major year-on-year improvement, reporting an AU$1m (£530,000) loss for Q3 2026, down from a $24m loss in the same quarter of 2025.
That said, the quarter was slightly weaker than Q2, with revenue falling and profitability slipping back into negative territory, as regulatory pressures and lower visitor numbers continued to weigh on performance.
Group revenue landed at $266m, down 12% quarter-on-quarter and slightly lower than the $268m recorded in the prior corresponding period.
The company posted an EBITDA loss of $1m, reversing the $6m profit it gained in Q2, though the result is still a marked improvement on 2025 figures driven by cost-cutting efforts.
Declines were largely fueled by ongoing soft performance in Sydney, where revenue dropped 10% versus the previous quarter and 9% year-on-year. Table games were a particular weak point, and the impact of mandatory carded play and cash limits continues to be felt – average daily revenue at the Sydney property is still roughly 20% below pre-reform levels.
Examples of these regulatory reforms include a $100 cash load-up limit for Victorian poker machines and a delayed rollout of $1,000 daily cash limits at New South Wales casinos, where the limit will remain at $5,000 until August 2027.
Across other locations, performance was mixed. The Gold Coast delivered modest year-on-year growth, supported by stronger electronic gaming and hospitality results, while Brisbane’s numbers were impacted by the transition out of the Destination Brisbane Consortium (DBC) joint venture and changes to the operator fee structure.
Cost reductions were a clear positive highlight, with operating expenses falling 11% quarter-on-quarter and 10% year-on-year. This reflects the early impact of “cost out” initiatives launched by the company’s new leadership team, including corporate streamlining and reviews of supplier costs.
Latest updates on The Star’s turnaround plan
Even so, The Star’s broader overall financial position remains fragile. Available cash dropped to $90m at the end of March, and the company is working against a tight deadline to complete refinancing by 15 May to avoid breaching its existing debt agreement.
A binding refinancing commitment with WhiteHawk Capital Partners, announced at the end of last month, is already in place, and all required regulatory approvals have been secured.
The refinancing package consists of a three-year facility totaling around $550m, which will be used to fully refinance the group’s existing debt while also providing extra liquidity.
A minimum liquidity requirement of $50m has been set for the first 12 months after financial close, which the company is on track to meet. The requirement rises to $75m between 12 and 18 months post-close, and $100m after that period.
Additional covenants include a minimum asset coverage ratio starting December 2026 and a minimum EBITDA threshold starting March 2027, alongside standard reporting obligations and default provisions.
An interest reserve account that will cover the first 12 months of interest payments will also be set up as part of the new financing structure.
“The Star is working to complete the refinancing as soon as possible, but no later than 15 May 2026, to meet the conditions of the waiver granted by existing SFA lenders,” a company statement read.
The Star has also made progress on its strategic reset, completing the first stage of its exit from the Brisbane joint venture with DBC. This step included the release of a large parent company guarantee tied to $1.4bn in debt facilities.
Financial challenges will not be resolved immediately
Despite these recent steps, The Star has reiterated that material uncertainty remains over its ability to continue as a going concern, with multiple interconnected factors including refinancing, regulatory outcomes and operational recovery still unresolved.
Bruce Mathieson Jnr, the company’s current Chief Executive Officer, has continued advancing the turnaround strategy, which included appointing two new Non-Executive Directors – Brooke Lindsay and Grant Bowie – this month.
The business remains in a transitional period following a $300m strategic investment from Bally’s Corporation and Investment Holdings late last year, a deal that will eventually give Bally’s a 56.7% stake in The Star.
The company is also navigating ongoing regulatory change across Australia, where a key recent policy focus has been cracking down on gambling advertising. The Murphy report, written by late MP Peta Murphy and holding 31 recommendations for Australian regulatory reform, has still not seen most of its suggestions implemented across the country.
For The Star, an immediate return to profitability was always highly unlikely. Despite the unavoidable pressures it faces from both internal and external sources, the company is in a much healthier position today than it was at the start of 2025, when it was grappling with losses of more than $300m.
This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content.
AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
(AsiaGameHub) - Tipico Sportwetten has kicked off a new “leadership era”, with Mate Bacic taking over from Axel Hefer as Chief Executive Officer of the largest sports betting and iGaming brand operating in the DACH region.
This leadership transition follows Hefer’s decision to resign from the new leadership team of Banijay Gaming – the division established in April 2025, after Banijay Group finalized its €3 billion acquisition of Tipico.
Hefer’s exit comes after he fulfilled his remit of restructuring Tipico to position it for an eventual multi-billion-euro sale. During his three-year tenure, the company pulled out of the US market, selling its domestic US operations to MGM Resorts, and purchased Admiral Austria to boost its regional presence.
The business ultimately became an acquisition target itself, when its former private equity owner CVC Capital reached an agreement to sell Tipico to Banijay in October 2025.
Speaking about his departure, Hefer said: “I joined the Tipico Group nearly three years ago with one clear goal: to lay the groundwork for the company’s future international growth. Now that the sale to Banijay Group is complete, my work here has been successfully finished.
“I am fully confident that with Mate Bacic leading the company and as part of Banijay Gaming, Tipico is extremely well positioned for future success. I wish Mate and the entire team all the best in the coming years.”
New leadership steers the business into its next chapter
Bacic, who has held executive roles at Tipico for almost a decade, has been promoted to the CEO position from the group’s existing senior leadership ranks.
As Managing Director of Tipico Retail Services, he played a key role in building and restructuring the operator’s land-based retail network, which now covers more than 1,250 outlets across Germany and Austria.
Most recently, he oversaw the integration of Admiral Austria into the wider group during his tenure as CEO of the Atlas Group. Before joining Tipico, Bacic held senior leadership positions at Telefónica Germany, bringing deep operational and commercial expertise to his new top role.
Discussing his new appointment, Bacic said: “I am thrilled to lead Tipico through this critical phase for the business. We have a powerful brand, a highly committed team, and trusted partners supporting us. Working alongside Banijay, we will speed up innovation efforts, invest in technology, and set new benchmarks for customer service.”
He added: “We aim to deliver the best and most secure experience possible for sports betting fans — both online and across our more than 1,250 retail shops. I also want to thank Axel for his reliable partnership and his significant contributions to putting Tipico in such a strong position for the future.”
Credit: Tobias Arhelger / Shutterstock
Under the revised leadership structure, Nicolas Béraud, former Betclic CEO, will serve as Chairman of the Board of Banijay Gaming. Joachim Baca, Chairman and former CEO of Tipico, will act as Vice-Chairman of the Board.
Operational leadership roles across the group’s core brand portfolio have also been reshuffled, with Julien Brun, previously Chief Operational Officer, stepping into the role of CEO of Betclic.
Banijay’s leadership team has given its full endorsement to this internal succession, with Béraud stating: “Following the completion of Banijay Gaming’s acquisition of the Tipico Group, I am convinced that Mate, with his extensive industry experience, in-depth understanding of the Tipico Group, and strong leadership capabilities, will make a major contribution to building our large-scale European gaming platform.
“Axel was an exceptional partner throughout the Betclic/Tipico transaction, and I wish him all the best for the next chapter of his career.”
This article is provided by a third-party. AsiaGameHub (https://asiagamehub.com/) makes no warranties regarding its content.
AsiaGameHub delivers targeted distribution for iGaming, Casino, and eSports, connecting 3,000+ premium Asian media outlets and 80,000+ specialized influencers across ASEAN.
香港, 2026年4月28日 - (亚太商讯 via SeaPRwire.com) - 4月28日，迈威（上海）生物科技股份有限公司（02493.HK，简称“迈威生物”）成功在香港联合交易所主板挂牌上市，成为又一家“A+H”两地上市的生物科技公司，亦是首家AtoH的18A公司。迈威生物本次全球发售4713.02万股H股，香港公开发售部分超额认购481.71倍，市场反响热烈。强劲的认购态势不仅为发行提供了稳固支撑，也折射出市场对于迈威研发管线与商业化前景的集体看好。迈威生物是一家具备创新研发及端到端产业化能力的中国制药公司。其核心产品9MW2821（靶向Nectin-4）在中国尿路上皮癌临床开发进度仅次于Padcev，且为全球首款进入宫颈癌关键III期试验的同靶点ADC。该产品已获得FDA三项快速通道认定及一项孤儿药资格认定，并获国家药监局两项突破性疗法认定。公司正同步推进该产品针对多项适应症的III期临床试验，计划于2027年提交尿路上皮癌和宫颈癌的NDA申请。若进展顺利，9MW2821有望成为中国首款覆盖多个实体瘤适应症的Nectin-4 ADC，潜在市场空间巨大。迈威生物已有君迈康(R)、迈利舒(R)、迈卫健(R)及迈粒生(R)四款产品实现商业化。2025年公司总收入达6.59亿元人民币，同比增长230%。对外授权合同总金额超过20亿美元，贡献显著。公司与Disc、Calico等国际药企达成的许可协议已带来可观的首付款和里程碑付款，充分验证了其技术成果的国际化变现能力。公司的生产端亦具备国际标准。江苏泰州生产基地符合中国GMP标准及欧盟EMA GMP标准，上海金山生产基地亦符合欧盟EMA GMP标准，为后续产品放量提供保障。迈威生物凭借其差异化的ADC管线及已兑现的商业化能力，加速推进核心产品的上市进程，在全球肿瘤及年龄相关疾病领域持续巩固其竞争优势。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
香港, 2026年4月28日 - (亚太商讯 via SeaPRwire.com) - 2026年4月24日，旭阳集团有限公司（简称"旭阳集团"）与杭氧集团股份有限公司（简称"杭氧集团"）在杭州正式签署战略合作协议。双方将立足京津冀雄和长三角区域，面向全国，在氢能供应体系、高端装备国产化、技术创新及产业投资等领域开展全方位、深层次合作，共同推动我国氢能产业高质量发展。旭阳集团在工业副产氢领域拥有超过30年深厚积累，是全球最大的独立焦炭生产商及供应商；全球最大焦化粗苯加工商、第二大高温煤焦油加工商和己内酰胺生产商(按产能计)，亦是中国最大的焦炉煤气制甲醇生产商和京津冀最大的高纯氢供应商(按产量计)，中国旭阳集团（1907.HK）2019年3月成功在香港联交所主板上市，已形成覆盖"制-储-运-加-用+研"的完整氢能产业链。杭氧集团股份有限公司（002430.SZ）2010年在深圳证券交易所上市，是世界一流的空分设备和低温石化装备供应商，中国气体的产业开拓者和引领者，亦是国内第一台空分设备制造者；其大型、特大型空分设备产量和销量全球第一，总体技术达到国际领先水平，在气体运营及氢能技术研发方面具备领先优势。此次合作是双方优势资源的战略级整合，将旭阳氢源基础与应用场景，与杭氧的装备技术及气体产业能力深度融合，为氢能全产业链生态建设注入强劲动力。聚焦三大合作方向，释放协同发展新动能本次合作将重点围绕氢能销售与供应体系的共建、高端装备国产化应用，以及技术创新与产业化落地展开。双方将通过业务对接与资源协同，构建"液氢生产基地+区域储氢枢纽+加氢站网络"三级供应体系，共同拓展工业、交通、电子、医药、航天等终端市场。同时，双方将联合推进氢能领域关键装备与系统的国产化进程，并在旭阳定州氢能生产基地共建氢能装备测试与技术创新中心，聚焦液氢及加氢站核心部件的验证与攻关，携手申报国家级科研项目及行业标准。为进一步深化合作，双方还拟共同出资设立合资公司，主营氢气/液氢销售、氢能装备制造及技术服务，加速科技成果的产业化落地。合作前景：从资源优势迈向全链引领此次战略合作，标志着旭阳集团氢能产业正加速从"资源优势"向"全链优势"跃升。通过与杭氧集团的强强联合，旭阳将有效补齐在高端装备和气体运营网络方面的关键环节，显著提升氢能产品的市场覆盖能力与流通效率，并借助国产化装备的规模化应用，降低全链条成本，增强核心竞争力。对于杭氧集团而言，合作将助其从传统空分及低温装备领域，深度切入工业副产氢这一丰富的氢能源头，拓展液氢及高纯氢的应用场景，抢占氢能装备与气体服务的市场先机。面向未来，双方将以此次合作为起点，构建可复制、可推广的氢能产业生态。未来合资公司的设立更将为双方带来长期稳定的业务增长极，推动旭阳集团从焦化龙头向全球领先的清洁能源解决方案提供商加速转型，同时也助力杭氧集团实现从装备制造向"装备+服务+运营"的产业链延伸。在国家"双碳"目标的引领下，旭阳与杭氧的携手，将为我国氢能产业的高端化、规模化和国际化发展树立新的标杆。杭氧集团党委副书记童俊表示："旭阳集团在工业副产氢及氢能应用场景方面具有独特优势。杭氧将全力支持双方深度合作，共同推动我国氢能产业迈向高端化、规模化、国际化。"旭阳集团高级副总裁张英伟表示："杭氧集团在低温装备和气体运营方面拥有世界级的技术实力。本次合作是旭阳氢能产业的关键跃升，我们将充分发挥互补优势，加快打造氢能产业生态，助力国家‘双碳’目标实现。"关于战略合作协议，双方已建立高层沟通机制和联合工作小组，确保合作高效落地。未来，旭阳集团将继续秉持开放、协同、共赢的理念，携手产业链优秀伙伴，为构建清洁低碳、安全高效的现代能源体系贡献旭阳力量。 Copyright 2026 亚太商讯 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
HONG KONG, Apr 28, 2026 - (ACN Newswire via SeaPRwire.com) - Driven by the continuous innovation in global biopharmaceutical technology, the steady rollout of favorable policies, and escalating clinical demands, the biopharmaceutical industry is ushering in a golden cycle of development. As a representative enterprise in China's innovative pharmaceutical sector, Mabwell (Shanghai) Bioscience Co., Ltd. (“Mabwell” or the “Company”, stock code: 02493.HK) has seized industry development opportunities by leveraging its profound R&D foundation, integrated whole-industry-chain advantages, and forward-looking global layout. Today, it officially listed on the Main Board of the Hong Kong Stock Exchange (HKEX), joining the biopharmaceutical sector of the Hong Kong stock market and opening a brand-new chapter in its international development.Reportedly, founded in 2017, Mabwell is a leading domestic innovative pharmaceutical enterprise, possessing premier innovative drug R&D capabilities and end-to-end whole-industry-chain capabilities that span from drug discovery to commercial sales. Since its establishment, the Company has been deeply engaged in therapeutic areas for major diseases such as oncology, immunology, ophthalmology, and orthopedics, and is committed to providing safer and more efficient innovative treatment solutions for patients worldwide.Rich and Diversified Product Pipeline Builds Core Competitive BarriersA rich and promising product portfolio serves as the core pillar for Mabwell’s steady development, as well as its key advantage in seizing first-mover opportunities in the market. With a long-term, deep-rooted presence in the innovative drug sector, the Company has built a diversified product pipeline featuring multiple categories and tiers. As of now, Mabwell has 4 commercialized products and 10 drug candidates: 1 in NDA stage,, 1 in preclinical stages, covering multiple high-potential therapeutic areas and supporting long-term growth.Mabwell’s self-developed core product, 9MW2821, fully demonstrates the Company’s leading edge in the ADC field. 9MW2821 is the most advanced among all Nectin-4-targeting ADCs for urothelial carcinoma (“UC”) in China in terms of clinical development progress, and only second to the globally blockbuster drug Padcev. Meanwhile, it is also the first Nectin-4-targeting ADC globally to enter the pivotal Phase III clinical trials for cervical cancer (“CC”), and triple-negative breast cancer (“TNBC”), boasting extensive market potential.Beyond 9MW2821, Mabwell continues to advance the R&D of ADC candidates targeting other novel targets and has built a comprehensive ADC pipeline portfolio. Its pipeline includes 7MW3711, an ADC specifically targeting B7-H3 (an immune checkpoint protein), and 7MW4911, an ADC specifically targeting CDH17. This layout further diversifies the Company’s footprint in oncology treatment and steadily consolidates its leading advantages in the ADC track.Notably, Mabwell has also strategically prioritized the layout of product pipelines covering monoclonal antibodies (“mAbs”), TCE bispecific antibodies, fusion proteins and small molecule drugs, fostering a pattern of coordinated development across multiple product categories. Its R&D portfolio includes: 9MW3811, a humanized monoclonal antibody targeting IL-11 for the treatment of fibrosis -related diseases and cancers; 9MW1911, the first domestically developed drug candidate approved for clinical development in China targeting ST2; 9MW3011, a recombinant humanized TMPRSS6 targeting mAb among the leading TMPRSS6-targeting therapies in terms of development status globally; and 6MW5311, the world’s first LILRB4/CD3-targeted TCE bispecific antibody filed for clinical trials. These candidates keep expanding the boundaries of the Company’s innovative drug research and development.Outstanding commercialization capabilities, expanding a global market footprintLeveraging its fully integrated industry chain capabilities and forward-looking commercialization strategy, Mabwell (Shanghai) Bioscience Co., Ltd. has continued to deliver tangible commercialization outcomes. In 2025, the Company’s Junmaikang® obtained marketing approval in Indonesia, while Mailisheng® and Maiweijian were approved for commercialization in Pakistan, marking steady progress in its international commercialization efforts.Since 2022, the Company has actively expanded overseas collaborations, entering into multiple landmark international partnership agreements and securing corresponding revenue-sharing arrangements. It has successfully penetrated emerging markets including Brazil, Indonesia, Saudi Arabia, and countries along the Belt and Road Initiative, establishing an extensive global commercial network.In terms of global partnerships, Mabwell has further deepened its international presence. In January 2023, the Company entered into an exclusive licensing agreement with Disc Medicine for 9MW3011, under which it is entitled to receive up to US$412.5 million in upfront payments, milestone payments, and royalties. In June 2025, it reached an exclusive licensing agreement with Calico Life Sciences for 9MW3811, with total potential consideration exceeding US$600 million, including upfront, milestone, and royalty payments. In October 2025, the Company signed an exclusive licensing agreement with Kalexo Bio for a novel dual-target siRNA candidate drug, further expanding the breadth and depth of its international market collaborations.Powerful Technology Platforms Lay a Solid Foundation for Innovation-Driven GrowthPowerful technology platforms serve as the core engine for sustained innovation at Mabwell, and are also pivotal to building differentiated competitive advantages. With deep commitment to technological R&D, the Company has established four core ADC technologies for which we possess proprietary intellectual property rights, providing strong support for the development of innovative drugs.Among these, DARfinity is a self-developed site-specific conjugation process that enables precise drug molecule conjugation; IDconnect is an optimized design of linker molecules that enhances the stability of the linkage between the antibody and toxins; Mtoxin is a class of camptothecin-based novel toxic molecules that are used as the “warhead” in the ADC to kill the targeted cells, providing more potent target cell killing effects; LysOnly is an innovative structure that allows conditional release of toxins, effectively improving the overall safety and efficacy of ADC drugs.These four proprietary technologies serve as the core pillars of our site-specific conjugation ADC development platform, synergistically enabling the Company to develop ADC products with better uniformity, stability, purity, and a superior efficacy and safety profile. This significantly improves pipeline R&D efficiency, allows rapid response to clinical and market demands, and continuously consolidates the Company's leading position in the ADC field.In addition, Mabwell continues to develop and upgrade other core technology platforms, forming a multi-technology synergistic development system. These platforms include the integrated high-efficiency antibody discovery platform and the T-cell engager (TCE)-based bi/tri-specific antibody development platform, among others. The TCE-based bi/tri-specific antibodies developed on these platforms can simultaneously and specifically bind to tumor-associated antigens and the T-cell CD3 epitope, thereby laying a solid technical foundation for the Company's strategic positioning in the field of immunotherapy.From an industry perspective, the global biopharmaceutical sector, as a core segment, has continued to gain momentum in recent years. The global oncology drug market grew from US$143.5 billion in 2019 to US$253.3 billion in 2024 with a CAGR of 12.0%, and is expected to further increase to US$375.9 billion, and US$548.2 billion in 2028, and 2032 respectively, with CAGRs of 10.4% from 2024 to 2028 and 9.9% from 2028 to 2032, respectively. This trend presents substantial growth opportunities for leading industry players like Mabwell, which possess core technologies and a globalized footprint.Driven by in-house R&D, supported by integrated end-to-end capabilities across the entire industry chain, and guided by a long-term global strategy, Mabwell continues to advance steadily in the innovative pharmaceutical sector. Leveraging a robust product pipeline, strong technological expertise, and well-established commercialization capabilities, the Company has built a solid competitive position. Its successful listing in Hong Kong will further accelerate the development of its core products, enhance its commercialization strategy, and strengthen its core competitiveness. This, in turn, is expected to position the Company at the forefront of the biopharmaceutical wave, with strong long-term growth potential that merits close market attention. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
HONG KONG, Apr 28, 2026 - (ACN Newswire via SeaPRwire.com) - Beijing 51WORLD Digital Twin Technology Co., Ltd. (“the Company”, Stock Code: 6651.HK) announced on 27 April 2026 the first grant of 940,200 restricted share units (RSUs) to 303 employees under its 10-year RSU Scheme, representing approximately 0.23% of the Company’s total issued shares.The underlying shares will be sourced from existing H Shares acquired by the Trust on the secondary market and/or treasury H Shares repurchased by the Company using its own funds. Vesting of the award shares shall be 25% after 12 months from acceptance, and the remaining 75% shall vest in 12 quarterly instalments at 6.25% each until fully vested.The RSU Scheme is intended to align the interests of the core team with the long-term development of the Company and enhance the incentive mechanism for talent attraction and retention. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
